Phase 3 Study of KW-6500 (Safety Study for Extended Long-Term Self-Injection at Home in Patients With Parkinson's Disease)
Latest Information Update: 11 Jul 2019
Price :
$35 *
At a glance
- Drugs Apomorphine (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- Sponsors Kyowa Hakko Kirin; Kyowa Kirin
- 06 Mar 2017 New trial record